assesses nutritional status of leukemia patients undergoing hematopoietic stem cell transplantation

Peng Liu,Zhao-Feng Zhang,Jing-Jing Cai,Bo-Shi Wang,Xia Yan
2012-01-01
Abstract:Hematopoietic stem cell transplantation (HSCT) is widely used in the treatment of hematological malignancies and some solid tumors (1,2). Patients with hematological malignancies are frequently accompanied with malnutrition (3). Prior to the transplantation, patients usually receive high-dose chemotherapy and/or general radiotherapy, which make their nutrition status injured in different extents (4,5). Nutritional status is an important variable for prognosis of diseases (6). Malnutrition patients have high incidence of complications and mortality (7), prolonged hospitalization days, increased medical costs (8), and poor quality of life (9). Malnutrition will influence the treatment effect of HSCT and the reconstitution of hematopoietic and immune functions (10). Therefore, correctly assessing the nutritional status of patients before and after HSCT is important for a successful transplantation and improving the quality of life after transplantation (11). Nutritional risk screening 2002 (NRS2002) is the first nutrition risk screening tool Original Article
What problem does this paper attempt to address?